Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

ANTIBIOTICS IN TREATMENT OF PANCREATIC FIBROSIS, WITH EMPHASIS ON TERRAMYCIN

ANTIBIOTICS IN TREATMENT OF PANCREATIC FIBROSIS, WITH EMPHASIS ON TERRAMYCIN The beneficial effects of aureomycin in the management of patients with pancreatic fibrosis (mucoviscidosis) have been demonstrated.1 An extension of observations begun three years ago, and including over 100 patients, shows a favorable response in over 90%. Anticipation of the appearance of refractoriness to aureomycin and the poor response of the occasional patient to aureomycin suggested the use of terramycin.2 The present report is an evaluation of terramycin in the treatment of 49 patients with pancreatic fibrosis. All patients, with two exceptions (the patients in cases 2 and 3), had pulmonary infections of varying severity. A brief note concerning the efficacy of terramycin has been made.3 A full description of this disease is given elsewhere.4 The main clinical features drawing attention to this condition in early infancy are hunger, with failure to gain weight on an adequate caloric intake; the passage of large, foul, and frequent http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

ANTIBIOTICS IN TREATMENT OF PANCREATIC FIBROSIS, WITH EMPHASIS ON TERRAMYCIN

Shwachman, H.; Silverman, B. K.; Patterson, P. R.; Zheutlin, L. J.
JAMA , Volume 149 (12) – Jul 19, 1952
Download PDF
8 pages

Loading next page...
 
/lp/american-medical-association/antibiotics-in-treatment-of-pancreatic-fibrosis-with-emphasis-on-Go0qdhR4Aa

References (13)

Publisher
American Medical Association
Copyright
Copyright © 1952 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1952.02930290023006
Publisher site
See Article on Publisher Site

Abstract

The beneficial effects of aureomycin in the management of patients with pancreatic fibrosis (mucoviscidosis) have been demonstrated.1 An extension of observations begun three years ago, and including over 100 patients, shows a favorable response in over 90%. Anticipation of the appearance of refractoriness to aureomycin and the poor response of the occasional patient to aureomycin suggested the use of terramycin.2 The present report is an evaluation of terramycin in the treatment of 49 patients with pancreatic fibrosis. All patients, with two exceptions (the patients in cases 2 and 3), had pulmonary infections of varying severity. A brief note concerning the efficacy of terramycin has been made.3 A full description of this disease is given elsewhere.4 The main clinical features drawing attention to this condition in early infancy are hunger, with failure to gain weight on an adequate caloric intake; the passage of large, foul, and frequent

Journal

JAMA – American Medical Association

Published: Jul 19, 1952

There are no references for this article.